Winters IP - Search Results

1

Oncogenic context shapes the fitness landscape of tumor suppression.

Blair LM, Juan JM, Sebastian L, Tran VB, Nie W, Wall GD, Gerceker M, Lai IK, Apilado EA, Grenot G, Amar D, Foggetti G, Do Carmo M, Ugur Z, Deng D, Chenchik A, Paz Zafra M, Dow LE, Politi K, MacQuitty JJ, Petrov DA, Winslow MM, Rosen MJ, Winters IP. Blair LM, et al. Among authors: winters ip. Nat Commun. 2023 Oct 12;14(1):6422. doi: 10.1038/s41467-023-42156-y. Nat Commun. 2023. PMID: 37828026 Free PMC article.

2

A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo.

Rogers ZN, McFarland CD, Winters IP, Naranjo S, Chuang CH, Petrov D, Winslow MM. Rogers ZN, et al. Among authors: winters ip. Nat Methods. 2017 Jul;14(7):737-742. doi: 10.1038/nmeth.4297. Epub 2017 May 22. Nat Methods. 2017. PMID: 28530655 Free PMC article.

3

Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity.

Winters IP, Chiou SH, Paulk NK, McFarland CD, Lalgudi PV, Ma RK, Lisowski L, Connolly AJ, Petrov DA, Kay MA, Winslow MM. Winters IP, et al. Nat Commun. 2017 Dec 12;8(1):2053. doi: 10.1038/s41467-017-01519-y. Nat Commun. 2017. PMID: 29233960 Free PMC article.

4

Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice.

Rogers ZN, McFarland CD, Winters IP, Seoane JA, Brady JJ, Yoon S, Curtis C, Petrov DA, Winslow MM. Rogers ZN, et al. Among authors: winters ip. Nat Genet. 2018 Apr;50(4):483-486. doi: 10.1038/s41588-018-0083-2. Epub 2018 Apr 2. Nat Genet. 2018. PMID: 29610476 Free PMC article.

5

Towards quantitative and multiplexed in vivo functional cancer genomics.

Winters IP, Murray CW, Winslow MM. Winters IP, et al. Nat Rev Genet. 2018 Dec;19(12):741-755. doi: 10.1038/s41576-018-0053-7. Nat Rev Genet. 2018. PMID: 30267031 Review.

6

Publisher Correction: Towards quantitative and multiplexed in vivo functional cancer genomics.

Winters IP, Murray CW, Winslow MM. Winters IP, et al. Nat Rev Genet. 2018 Dec;19(12):801. doi: 10.1038/s41576-018-0062-6. Nat Rev Genet. 2018. PMID: 30327497

7

Quantitative In Vivo Analyses Reveal a Complex Pharmacogenomic Landscape in Lung Adenocarcinoma.

Li C, Lin WY, Rizvi H, Cai H, McFarland CD, Rogers ZN, Yousefi M, Winters IP, Rudin CM, Petrov DA, Winslow MM. Li C, et al. Among authors: winters ip. Cancer Res. 2021 Sep 1;81(17):4570-4580. doi: 10.1158/0008-5472.CAN-21-0716. Epub 2021 Jul 2. Cancer Res. 2021. PMID: 34215621 Free PMC article.

8

Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung Adenocarcinoma.

Caswell DR, Chuang CH, Ma RK, Winters IP, Snyder EL, Winslow MM. Caswell DR, et al. Among authors: winters ip. Mol Cancer Res. 2018 Nov;16(11):1737-1749. doi: 10.1158/1541-7786.MCR-18-0392. Epub 2018 Jul 12. Mol Cancer Res. 2018. PMID: 30002193 Free PMC article.

9

An LKB1-SIK Axis Suppresses Lung Tumor Growth and Controls Differentiation.

Murray CW, Brady JJ, Tsai MK, Li C, Winters IP, Tang R, Andrejka L, Ma RK, Kunder CA, Chu P, Winslow MM. Murray CW, et al. Among authors: winters ip. Cancer Discov. 2019 Nov;9(11):1590-1605. doi: 10.1158/2159-8290.CD-18-1237. Epub 2019 Jul 26. Cancer Discov. 2019. PMID: 31350327 Free PMC article.

10

Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program.

Bieging-Rolett KT, Kaiser AM, Morgens DW, Boutelle AM, Seoane JA, Van Nostrand EL, Zhu C, Houlihan SL, Mello SS, Yee BA, McClendon J, Pierce SE, Winters IP, Wang M, Connolly AJ, Lowe SW, Curtis C, Yeo GW, Winslow MM, Bassik MC, Attardi LD. Bieging-Rolett KT, et al. Among authors: winters ip. Mol Cell. 2020 Nov 5;80(3):452-469.e9. doi: 10.1016/j.molcel.2020.10.022. Mol Cell. 2020. PMID: 33157015 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page